Cornell and the Cayuga Health System are donating COVID-19 testing and analysis to the Ithaca City School District, testing more than 1,200 students this week as the district prepares to reopen for in-person instruction Oct. 5.
When Kaavian Shariati ’20 learned he had Type 1 diabetes shortly before arriving at Cornell, he was shocked not only by his new responsibilities – monitoring his insulin levels day and night – but by the state of diabetes research.
In the 1800s, Americans were targeted with advertisements for what were often considered “cure-all” medicines, presented in colorful trade cards – now part of a Weill Cornell Medicine collection.
Radiation therapy appears to increase the expression of genes with mutations that induce an immune response to malignant cells, according to preclinical research by Weill Cornell Medicine.
The annual event showcased the wide range of cancer research taking place across Cornell colleges and campuses, and allowed faculty and students to identify potential areas for collaboration.
A single protein derived from a common strain of bacteria found in the soil will offer scientists a more precise way to edit RNA, according to new Cornell food science research.
Researchers at Weill Cornell Medicine and Cornell’s Ithaca campus have developed a new computational method for studying genetic and environmental interactions and how they influence disease risk.
New York Gov. Andrew M. Cuomo on March 24 announced the launch of the state’s free, online Citizen Public Health Training Course, delivered by the state Department of Health in partnership with Cornell.
David Russell, the William Kaplan Professor of Infection Biology in the Department of Microbiology and Immunology, has been awarded a $2 million grant from the Mueller Health Foundation to develop new treatment regimens for tuberculosis.
In a first-of-its-kind clinical trial, a human has received a 3D-bioprinted ear implant grown from the patient’s own living cells – thanks to a technology platform developed by a Cornellian-founded startup company.